Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Ashley, Elizabeth A ^a   Pinoges, Loretxu ^a   Turyakira, Eleanor ^a   Dorsey, Grant ^b   Checchi, Francesco ^c   Bukirwa, Hasifa ^d   Van Den Broek, Ingrid ^e,f   Zongo, Issaka ^g   Urruta, Pedro Pablo Palma ^e   Van Herp, Michel ^h   Balkan, Suna ^e   Taylor, Walter R ^i,j   Olliaro, Piero ^k,l   Guthmann, Jean Paul ^a,m  

^a EPICENTRE   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Uganda Malaria Surveillance Project   (Uganda)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g Centre National de la Recherche Scientifique et Technologique   (Burkina Faso)

^h MÉDECINS SANS FRONTIÈRES   (Belgium)

ⁱ OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m INSTITUT DE VEILLE SANITAIRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FANSIDAR; FLUORENE DERIVATIVE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

AFRICA; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; GENOTYPE; HUMAN; IN VIVO STUDY; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; METHODOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SURVIVAL; TREATMENT DURATION; WORLD HEALTH ORGANIZATION; ANIMAL; DRUG COMBINATION; DRUG EFFECT; GENETICS; PARASITOLOGY; PLASMODIUM FALCIPARUM; STATISTICS; TREATMENT OUTCOME;

AFRICA; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DATABASES AS TOPIC; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

EID: 50649121593     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-154     Document Type: Article

References (30)

1. Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. JP Guthmann L Pinoges F Checchi S Cousens S Balkan M van Herp D Legros P Olliaro, Antimicrob Agents Chemother 2006 50 3734 3739 16954313 10.1128/AAC.01618-05
2. The assessment of antimalarial drug efficacy. NJ White, Trends Parasitol 2002 18 458 464 10.1016/S1471-4922(02)02373-5 12377597
3. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. K Stepniewska WR Taylor M Mayxay R Price F Smithuis JP Guthmann K Barnes HY Myint M Adjuik P Olliaro S Pukrittayakamee S Looareesuwan TT Hien J Farrar F Nosten NP Day NJ White, Antimicrob Agents Chemother 2004 48 4271 4280 15504852 10.1128/AAC.48.11.4271-4280.2004
4. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. K Stepniewska NJ White, Malar J 2006 5 127 17187673 10.1186/1475-2875-5-127
5. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. World Health Organization, Geneva 1996
6. Monitoring Antimalarial Drug Resistance - Report of a WHO Consultation. World Health Organization, Geneva, Switzerland, 3-5 December 2001
7. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva 2003
8. Susceptibility of Plasmodium falciparum to antimalarial drugs. World Health Organization, Geneva 2005
9. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. RN Price G Dorsey EA Ashley KI Barnes JK Baird U d'Alessandro PJ Guerin MK Laufer I Naidoo F Nosten P Olliaro CV Plowe P Ringwald CH Sibley K Stepniewska NJ White, Malar J 2007 6 119 17822532 10.1186/1475-2875-6-119
10. The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005. WJ Collins B Greenhouse PJ Rosenthal G Dorsey, Malar J 2006 5 122 17169157 10.1186/1475-2875-5-122
11. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. B Greenhouse C Dokomajilar A Hubbard PJ Rosenthal G Dorsey, Antimicrob Agents Chemother 2007 51 3096 3103 17591848 10.1128/AAC.00159-07
12. Guidelines for the treatment of malaria. World Health Organization, Geneva 2006 http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf
13. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. N Bakyaita G Dorsey A Yeka K Banek SG Staedke MR Kamya A Talisuna F Kironde S Nsobya A Kilian A Reingold PJ Rosenthal F Wabwire-Mangen, Am J Trop Med Hyg 2005 72 573 580 15891132
14. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zerekore. M Bonnet C Roper M Felix L Coulibaly GM Kankolongo JP Guthmann, Malar J 2007 6 54 17477865 10.1186/1475-2875-6-54
15. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. H Bukirwa A Yeka MR Kamya A Talisuna K Banek N Bakyaita JB Rwakimari PJ Rosenthal F Wabwire-Mangen G Dorsey SG Staedke, PLoS Clinical Trials 2006 1 e7 16871329 10.1371/journal.pctr.0010007
16. Efficacy and effectiveness of the combination of sulfadoxine/ pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. E Depoortere JP Guthmann J Presse N Sipilanyambe E Nkandu S Balkan PE de Pecoulas D Legros, Trop Med Int Health 2005 10 139 145 10.1111/j.1365-3156.2004.01363.x 15679556
17. Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. F Grandesso A Hagerman S Kamara E Lam F Checchi S Balkan G Scollo R Durand JP Guthmann, Trop Med Int Health 2006 11 1017 1021 10.1111/j.1365-3156. 2006.01655.x 16827702
18. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine- pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine +artesunate in Huambo and Bie provinces, central Angola. JP Guthmann J Ampuero F Fortes C van Overmeir V Gaboulaud S Tobback J Dunand N Saraiva P Gillet J Franco A Denoncin M van Herp S Balkan JC Dujardin U D'Alessandro D Legros, Trans R Soc Trop Med Hyg 2005 99 485 492 15876443
19. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. JP Guthmann S Cohuet C Rigutto F Fortes N Saraiva J Kiguli J Kyomuhendo M Francis F Noel M Mulemba S Balkan, Am J Trop Med Hyg 2006 75 143 145 16837721
20. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. S Hamour Y Melaku K Keus J Wambugu S Atkin J Montgomery N Ford C Hook F Checchi, Trans R Soc Trop Med Hyg 2005 99 548 554 10.1016/j.trstmh.2004.10.003 15869770
21. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. SG Staedke A Mpimbaza MR Kamya BK Nzarubara G Dorsey PJ Rosenthal, Lancet 2004 364 1950 1957 10.1016/S0140-6736(04)17478-3 15567011
22. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. TD Swarthout I van den Broek G Kayembe J Montgomery H Pota C Roper, Trop Med Int Health 2006 11 1503 1511 10.1111/j.1365-3156.2006.01710.x 17002724
23. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. I van den Broek C Kitz S Al Attas F Libama M Balasegaram JP Guthmann, Malar J 2006 5 113 17125496 10.1186/1475-2875-5-113
24. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. A Yeka K Banek N Bakyaita SG Staedke MR Kamya A Talisuna F Kironde SL Nsobya A Kilian M Slater A Reingold PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Med 2005 2 e190 16033307 10.1371/journal.pmed.0020190
25. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. I Zongo G Dorsey N Rouamba C Dokomajilar M Lankoande JB Ouedraogo PJ Rosenthal, Am J Trop Med Hyg 2005 73 826 832 16282288
26. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. I Zongo G Dorsey N Rouamba H Tinto C Dokomajilar RT Guiguemde PJ Rosenthal JB Ouedraogo, Lancet 2007 369 491 498 10.1016/S0140-6736(07)60236-0 17292769
27. Molecular genotyping to distinguish between recrudescent and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. K Mugittu M Adjuik G Snounou F Ntoumi W Taylor H Mshinda P Olliaro HP Beck, Trop Med Int Health 2006 11 1350 1359 10.1111/j.1365-3156.2006.01688.x 16930256
28. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment. K Mugittu G Priotto JP Guthmann J Kiguli M Adjuik G Snounou HP Beck H Mshinda PL Olliaro WR Taylor, Trop Med Int Health 2007 12 219 223 17300628
29. Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. PO Olliaro L Pinoges F Checchi M Vaillant JP Guthmann, Trop Med Int Health 2008 13 83 90 18291006
30. A database of antimalarial drug resistance. CH Sibley P Ringwald, Malar J 2006 5 48 16774688 10.1186/1475-2875-5-48